CASP3 and carcinoma: Further investigations revealed impaired mitochondrial functions through reduced mitochondrial membrane potential and increased caspase 3 and caspase 9 levels in carcinoma cells treated with the C2C12-EVs, suggesting mitochondrial-dependent apoptosis mediated by the intrinsic pathway.